SCIENCE advances fastest when data and conclusions are shared as quickly as possible. Yet it is common practice for medical researchers to hoard results for months or years until research is published in an academic journal. Even then, the data underpinning a study are often not made public.
This is not about Republicans versus Democrats. It is about a more fundamental divide, between those who believe in evidence as a basis for life-altering and nation-defining decisions and those who adhere unflinchingly to dogma.
On the day of the hearing between Elsevier and the Dutch universities ScienceGuide has uncovered the contract which publicity was the centre of the dispute. The open access paragraph in the contract reveals how Elsevier plans to fight open access every step of the way.